Eagle Health Holdings Limited announced that it has entered into a Distribution Agreement with Zoono Group Limited for distributing Zoono's products in China. In accordance with the Agreement, Eagle and Zoono have a "co-branding" arrangement whereby Eagle will arrange for the bulk import of Zoono's formulations to its wholly owned GMP certified pharmaceutical facility in Xiamen China, where Eagle will carry out the labelling, packaging and distribution into Eagle's extensive existing channels. Under the co-branding arrangement Zoono's formulations will carry the renowned and trusted Eagle logo, with bilingual packaging, indicating "powered by" Zoono. Eagle will have exclusive distribution rights to the Eagle `co-branded' products, as well as holding
preferred partner status for Zoono branded products for offline retail sales.